Clinical Trial Update: A Study to Evaluate Safety, Side Effects, Muscle Activity and Speed of Gastric Emptying of GSK962040 [Phase 1]

View source ↗

Summary

Phase 1 study to evaluate safety, side effects, muscle activity, and gastric emptying speed of GSK962040 in gastroparesis; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroparesis

Drugs mentioned

• GSK962040

Snippet

Sponsor: GlaxoSmithKline | Conditions: Gastroparesis | Phase 1 | Status: COMPLETED